Hydromer, Inc. Surpasses 40 Years as a Global Supplier of Specialty Coatings for Medical and Industrial Applications and Announces New North Carolina Facility Fully Operational with New Expanded Capabilities

0


[ad_1]

Hydromer, Inc.

Hydromer, Inc. surpasses 40 years as a global supplier of specialty coatings for medical and industrial applications and announces that its new facility in North Carolina is fully operational with new expanded capabilities.

Hydromer, Inc. surpasses 40 years as a global supplier of specialty coatings for medical and industrial applications and announces that its new facility in North Carolina is fully operational with new expanded capabilities.

Concord, NC, September 23, 2021 (GLOBE NEWSWIRE) – via NewMediaWire – Hydromer, Inc. (the “Company”) (HYDI: OTC):

Hydromer, a global supplier of coatings for medical devices and industrial applications, is delighted to announce that our brand new facility with extensive new capabilities is fully operational, marking the proud opportunity to serve global customers for over 40 years. Located in Concord (a suburb of Charlotte), North Carolina, our new facility is a fully FDA certified, ISO9001: 2015 and ISO13485: 2016 approved site, designed to the latest specifications to accommodate all business functions under a single roof, offering the following notable advantages:

  • Collaborative research and development (R&D) and manufacturing of coating formulations with production capabilities ranging from initial customer product prototype to scale-up to large quantities, including, but not limited to, the contract development and supply of custom coatings according to customer needs.

  • Coatings which can be heat or UV cured, in solvent and water based versions to suit any type of coating requirements.

  • Offering a wide range of surface modification processes such as corona treatment, plasma treatment, solvent cleaning and others, for difficult materials which are becoming standard in many interventional medical devices such as microcatheters and endoluminal surgeries.

  • Very large modular ISO Class 8 cleanroom to accommodate customer devices of various sizes and quantities, including device coating capacities up to 20 feet (600 cm) in length.

  • Precision coating under magnification for micro-devices with tight tolerances.

  • Expertise in coating complex devices such as balloons, complex IDs, multi-lights and others, including emerging 3D printed parts used in device development.

  • Extensive analytical capabilities such as gas chromatography with mass spectroscopy (GC-MS), high performance liquid chromatography (HPLC), Fourier transmission infrared (FTIR), spectrophotometers, contact angle, the ultra-high resolution video scanning microscope and other specialized scientific tools. instrumentation.

  • Extensive testing capabilities including American Society for Testing and Materials (ASTM), International Organization for Standardization (ISO), European Conformity (CE) and other standardized methods for friction / pinch force, abrasion resistance, light transmission, hardness, adhesion, surface tensions and others.

  • Custom coating equipment design services developed in-house and tailored to specific customer needs.

  • Quality assurance offering OQ and PQ validations for customer devices, both new and innovative devices, as well as retired devices, to ensure that customer requirements are met.

Our coating formulations marketed under the brands HYDROMER â„¢, LUXERE â„¢, BRILLIANZ â„¢ and GLACIAL â„¢ offer the highest lubricity, exceptional durability, lowest particle size, fog and gel control, thrombo-resistance and many more. other sought-after performance that customers need to differentiate their medical devices and industrial products. Most of our medical grade coatings have FDA MAF files to assist our customers with their regulatory submissions.

“We are proud of our 40-year heritage, proven innovation, and outstanding customer service for the benefit of our customers large and small. We are very excited to add these additional capabilities to continue the journey as a ‘one stop / full service provider’ of world class products and services to customers around the world ”, said Peter M. von Dyck, CEO of Hydromer.

Hydromer’s legacy of innovation provides many technologies and areas of expertise that are in high demand, antimicrobial coating capabilities, a range of alcohol and herbal disinfection products, proprietary technologies including a range of anti-fog and condensation control products; the company expects a continued increase in global demand for these products given the current ecosystem more focused on infection control.

About Hydromer®

Hydromer®, Inc & Subsidiary (the “Company”) is one of the world’s leading providers of ISO 9001: 2015 Business-to-Business (B2B) surface modification and coating solutions providing research and development capabilities on polymers and manufacturing services for a wide variety of applications. We are a US public corporation domiciled in Concord, North Carolina. Our customers are located in the United States of America, Europe and Asia-Pacific. The company was formed in 1980, initially incorporated in the state of New Jersey. Driven by the strategic business objectives and goals of the new management of the company, the operations of the Company have been restructured into two distinct business lines: industrial and medical. We have successfully developed more than 90 proprietary formulations and obtained more than 400 patents worldwide at various points in our history, including antimicrobial, anti-fog, anti-freeze, condensation control, hydrophilic and thromboresistant coatings. The company’s track record of innovation is an integral part of more than four decades of sustainable revenue from product and service sales, royalties and support agreements.

For the latest information on Hydromer, Inc. and its products, please visit our website at www.hydromer.com or contact us at [email protected]

Ravi Rangarajan

(908) 722-5000 Ext. 214

[email protected]

Attachment

[ad_2]

Share.

Leave A Reply